Takeda Pharms Na patents expiration
1. Prevacid Iv patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7396841 | TAKEDA PHARMS NA | Injections |
Aug, 2021
(2 years ago) | |
|
US7396841 (Pediatric) | TAKEDA PHARMS NA | Injections |
Feb, 2022
(2 years ago) | |
Drugs and Companies using LANSOPRAZOLE ingredient
Market Authorisation Date: 27 May, 2004
Treatment: When patients are unable to take the oral formulations, prevacid iv, for injection is indicated as an alternative for the short-term treatment (up to 7 days) of all grades of erosive esophagitis
Dosage: INJECTABLE;INTRAVENOUS
More Information on Dosage
PREVACID IV family patents
